ETH47
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ETH47, covering 2025-07-08 to 2025-08-11. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge [Phase 2]